ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

Senators Urge Grassroots Support For Health Research Fund Legislation

May 16, 1997

Cancer Letter Adds Associate Editor

July 19, 1985

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004